The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) project has published a new paper in the European Journal of Nuclear Medicine and Molecular Imaging, entitled “Quantification of amyloid PET for future clinical use: a state-of-the-art review”. In this article, methods for quantification of static amyloid PET scans are summarised and compared along with a discussion of the overall utility of amyloid PET quantification in routine clinical practice, observational research, and clinical trials. The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. The Joint Undertaking receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA. Congratulations to the authors! The paper can be read here: https://doi.org/10.1007/s00259-022-05784-y